REG vs ZNTL · P/E 34, rev $1.45B vs $257.7M cap
Regency Centers Corporation (REG) versus Zentalis Pharmaceuticals Llc (ZNTL) — a side-by-side from cached financials, not a winner call.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Zentalis Pharmaceuticals Llc (ZNTL) is a biotechnology company listed on NASDAQ.
Latest reported REG revenue for 2024-12-31 was $1.45B. Net income was $409.8M. Revenue was up 9.9% from 2023-12-31 to 2024-12-31. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Latest reported ZNTL revenue for 2025-09-30 was $0. Net income was -$26.7M. ZNTL currently screens at market cap $257.7M.
REG currently screens at market cap $12.93B and trailing P/E 33.5. ZNTL currently screens at market cap $257.7M.
Not investment advice. Open the REG and ZNTL stock pages for the full models.
Not investment advice.